Table 2.
Chest CT manifestations of patients with TM infection (n = 147)
| CT Feature | anti-IFN-γ autoantibody (+) (n = 54) | HIV (+) (n = 93) | X2 | P |
|---|---|---|---|---|
| Lung change | ||||
| Consolidation | 39 (72%) | 22 (24%) | 33.192 | <0.001 |
| GGO | 24 (44%) | 26 (28%) | 4.138 | 0.042 |
| Fibrous cord‑like lesions | 47 (87%) | 50 (54%) | 16.582 | <0.001 |
| Sporadic nodules(>5 mm, <3 cm) | 40 (74%) | 52 (56%) | 4.811 | 0.028 |
| Diffuse nodules(<5 mm) | 6 (11%) | 16 (17%) | 0.997 | 0.318 |
| Solid masses(>3 cm) | 11 (20%) | 11 (12%) | 1.959 | 0.162 |
| Vacuole sign | 15 (28%) | 21 (23%) | 0.499 | 0.480 |
| Emphysema | 16 (30%) | 23 (25%) | 0.421 | 0.517 |
| Interlobular septum thickening | 12 (22%) | 7 (8%) | 6.555 | 0.010 |
| Bronchial change | ||||
| Air bronchogram | 34 (63%) | 11 (12%) | 42.055 | <0.001 |
| Thickening of the bronchial vascular bundle | 9 (17%) | 9 (10%) | 1.553 | 0.213 |
| Pleural change | ||||
| Pleural effusion | 32 (59%) | 23 (25%) | 17.394 | <0.001 |
| Thickening of pleura | 32 (59%) | 9 (10%) | 41.759 | <0.001 |
| Extrapulmonary manifestations | ||||
| Pericardial effusion | 10 (19%) | 17 (18%) | 0.001 | 0.971 |
| Enlarged lymph nodes | 41 (76%) | 39 (42%) | 15.913 | <0.001 |
| Lesion distribution | ||||
| Bilateral | 42 (78%) | 68 (73%) | 0.394 | 0.530 |
| Peripheral and central | 38 (70%) | 46 (49%) | 6.098 | 0.014 |
| ≥2 lobes affected | 49 (90%) | 73 (78%) | 3.630 | 0.057 |
Note—GGO = ground-glass opacities